FDA’s Curtailed Authority to Regulate Lab-Developed Tests

FDA’s Curtailed Authority to Regulate Lab-Developed Tests

Online event
Thursday, Apr 30 from 4:15 pm to 5:15 pm EDT
Overview

Invitation to Register!

The Law & Health Care Program at the University of Maryland Francis King Carey School of Law invites you to join us as we welcome Reshma Ramachandran, Assistant Professor of Medicine, Yale School of Medicine for the second Spring event in the 2025/2026 Rothenberg Speaker Series. This year’s series will focus on the future of food, drug and medical device regulation. Professor Ramachandran's talk is titled "Implications for Patients and Public Health of FDA’s Curtailed Authority to Regulate Lab-Developed Tests."

Reshma Ramachandran, MD, MPP, MHS is an Assistant Professor, board-certified family physician, and health services researcher. Her research focuses on the realignment of incentives for healthcare stakeholders including pharmaceutical companies, hospitals, and universities towards prioritizing equitable patient access to safe, effective health technologies. She co-directs the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, an interdisciplinary initiative aligning research on medical product evaluation, approval, and coverage to advance policies that improve patient health and healthcare. Prior to this role, Reshma worked as research faculty as part of the Innovation + Design Enabling Access (IDEA) Initiative at the Johns Hopkins Bloomberg School of Public Health, where she focused on policies to address the global challenge of antimicrobial resistance and unaffordable access to prescription drugs. Dr. Ramachandran was trained in both medicine at the Alpert Medical School at Brown University and in public policy at the Harvard Kennedy School of Government. She completed her family medicine residency at Kaiser Permanente Los Angeles Medical Center and a health services research and policy fellowship at the National Clinician Scholars Program at Yale. Previously, she served as the first PharmFree Fellow with the American Medical Student Association focused on removing the undue influence of pharmaceutical companies on prescribing behavior and medical education. She is on the board of directors for the non-profit organization, Doctors for America.

This event is free, but registration is required. You will receive information on how to access the event in a separate email 48 hours before the webinar begins. If you have questions, please contact Gehan Girguis at ggirguis@law.umaryland.edu. This event will be recorded.

You can find additional information about the Rothenberg Speaker Series and past speakers' talks here.

Invitation to Register!

The Law & Health Care Program at the University of Maryland Francis King Carey School of Law invites you to join us as we welcome Reshma Ramachandran, Assistant Professor of Medicine, Yale School of Medicine for the second Spring event in the 2025/2026 Rothenberg Speaker Series. This year’s series will focus on the future of food, drug and medical device regulation. Professor Ramachandran's talk is titled "Implications for Patients and Public Health of FDA’s Curtailed Authority to Regulate Lab-Developed Tests."

Reshma Ramachandran, MD, MPP, MHS is an Assistant Professor, board-certified family physician, and health services researcher. Her research focuses on the realignment of incentives for healthcare stakeholders including pharmaceutical companies, hospitals, and universities towards prioritizing equitable patient access to safe, effective health technologies. She co-directs the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, an interdisciplinary initiative aligning research on medical product evaluation, approval, and coverage to advance policies that improve patient health and healthcare. Prior to this role, Reshma worked as research faculty as part of the Innovation + Design Enabling Access (IDEA) Initiative at the Johns Hopkins Bloomberg School of Public Health, where she focused on policies to address the global challenge of antimicrobial resistance and unaffordable access to prescription drugs. Dr. Ramachandran was trained in both medicine at the Alpert Medical School at Brown University and in public policy at the Harvard Kennedy School of Government. She completed her family medicine residency at Kaiser Permanente Los Angeles Medical Center and a health services research and policy fellowship at the National Clinician Scholars Program at Yale. Previously, she served as the first PharmFree Fellow with the American Medical Student Association focused on removing the undue influence of pharmaceutical companies on prescribing behavior and medical education. She is on the board of directors for the non-profit organization, Doctors for America.

This event is free, but registration is required. You will receive information on how to access the event in a separate email 48 hours before the webinar begins. If you have questions, please contact Gehan Girguis at ggirguis@law.umaryland.edu. This event will be recorded.

You can find additional information about the Rothenberg Speaker Series and past speakers' talks here.

Good to know

Highlights

  • 1 hour
  • Online

Location

Online event

Organized by
Law & Health Care Program at Maryland Carey Law
Followers--
Events34
Hosting5 years
Report this event